Preclinical study identifies possible therapeutic target for cardiovascular risk factors that avoid the common problem of an increased risk of fatty liver disease.
Fatty Liver Disease (Non-Alcoholic)
Basic science research explores the effects of impaired glycine metabolism in nonalcoholic fatty liver disease and how to potentially use glycine-based treatment to help people with NAFLD.
A Michigan Medicine team looks into the prevalence of NAFLD in patients with heart failure with preserved ejection fraction.
Mice lacking E4BP4 were protected against diet’s damaging effects.
A team of experts compared rates of cirrhosis, cardiovascular disease and metabolic abnormalities between patients with fatty liver disease who were of normal weight and overweight or obese.